Variant report
Variant | esv3351653 |
---|---|
Chromosome Location | chr15:39012327-39012868 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs371242670 | chr15:39012371-39012372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138593461 | chr15:39012372-39012373 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73388145 | chr15:39012386-39012387 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs570170144 | chr15:39012403-39012404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562843014 | chr15:39012449-39012450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374534564 | chr15:39012490-39012491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs180749310 | chr15:39012496-39012497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs79838584 | chr15:39012524-39012525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs77087158 | chr15:39012536-39012537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs8024474 | chr15:39012579-39012580 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs149263921 | chr15:39012614-39012615 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184551676 | chr15:39012621-39012622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565823296 | chr15:39012635-39012636 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144557883 | chr15:39012654-39012655 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs367901302 | chr15:39012677-39012678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148043788 | chr15:39012689-39012690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556977756 | chr15:39012697-39012698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs141724993 | chr15:39012716-39012717 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542214296 | chr15:39012721-39012722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560578881 | chr15:39012722-39012723 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529530669 | chr15:39012729-39012730 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541678823 | chr15:39012739-39012740 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs78532716 | chr15:39012751-39012752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs16967268 | chr15:39012762-39012763 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs189373614 | chr15:39012793-39012794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs76304306 | chr15:39012799-39012800 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114461401 | chr15:39012804-39012805 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570610341 | chr15:39012853-39012854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs531075247 | chr15:39012858-39012859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs569790630 | chr15:39012860-39012861 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
HDAC8 | 0 | CNVD |
NIPBL | 0 | CNVD |
RAD21 | 0 | CNVD |
SMC1A | 0 | CNVD |
SMC3 | 0 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Angelman syndrome | 16183798 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21785460 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Autism | 19204725 | CNVD |
Schizophrenia | 19204725 | CNVD |
Schizophrenia | 19149910 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Cancer | 17440070 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21129771 | CNVD |
Breast cancer | 21045282 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 22032731 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ependymoma | 19289631 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:39006400-39025000 | Weak transcription | Primary T regulatory cells fromperipheralblood | blood |
2 | chr15:39007000-39013400 | Weak transcription | HSMMtube | muscle |
3 | chr15:39007600-39013400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr15:39007800-39013200 | Weak transcription | Muscle Satellite Cultured Cells | -- |
5 | chr15:39008000-39013200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr15:39008200-39013000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr15:39008200-39013400 | Weak transcription | NH-A | brain |
8 | chr15:39008200-39013400 | Weak transcription | NHLF | lung |
9 | chr15:39008400-39013000 | Weak transcription | Osteobl | bone |
10 | chr15:39008400-39013200 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
11 | chr15:39008400-39013800 | Weak transcription | HMEC | breast |
12 | chr15:39008600-39013000 | Weak transcription | HSMM | muscle |
13 | chr15:39012600-39013200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr15:39012600-39013600 | Enhancers | Fetal Muscle Leg | muscle |